Format

Send to

Choose Destination
Neuropsychopharmacology. 2016 Apr;41(5):1274-85. doi: 10.1038/npp.2015.277. Epub 2015 Sep 9.

Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia.

Author information

1
Cognition, Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
2
School of Psychology, University of Birmingham, Birmingham, UK.
3
Beth Israel Deaconess Medical Center, EEG Lab, Neurology, Boston, MA, USA.
4
Harvard Medical School, Department of Neurology, Boston, MA, USA.
5
School of Psychological Sciences and Monash Biomedical Imaging, Monash University, Clayton, VIC, Australia.

Abstract

The prevalence of treatment-resistant schizophrenia points to a discrete illness subtype, but to date its pathophysiologic characteristics are undetermined. Information transfer from ventral to dorsal striatum depends on both striato-cortico-striatal and striato-nigro-striatal subcircuits, yet although the functional integrity of the former appears to track improvement of positive symptoms of schizophrenia, the latter have received little experimental attention in relation to the illness. Here, in a sample of individuals with schizophrenia stratified by treatment resistance and matched controls, functional pathways involving four foci along the striatal axis were assessed to test the hypothesis that treatment-resistant and non-refractory patients would exhibit contrasting patterns of resting striatal connectivity. Compared with non-refractory patients, treatment-resistant individuals exhibited reduced connectivity between ventral striatum and substantia nigra. Furthermore, disturbance to corticostriatal connectivity was more pervasive in treatment-resistant individuals. The occurrence of a more distributed pattern of abnormality may contribute to the failure of medication to treat symptoms in these individuals. This work strongly supports the notion of pathophysiologic divergence between individuals with schizophrenia classified by treatment-resistance criteria.

PMID:
26346637
PMCID:
PMC4793111
DOI:
10.1038/npp.2015.277
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center